HIVE(HIVE)
HIVE
$2.88—
NASDAQ
$2.88—
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $364M | $513M |
| Low | $331M | $472M |
| High | $408M | $553M |
| EBITDA Avg | $-16M | $164M |
| Low | $-43M | $132M |
| High | $10M | $195M |
| EBIT Avg | $-206M | $-63M |
| Low | $-233M | $-95M |
| High | $-179M | $-32M |
| Net Income Avg | $-208M | $-66M |
| Low | $-235M | $-97M |
| High | $-182M | $-34M |
| EPS Avg | $-0.91 | $-0.29 |
| Low | $-1.04 | $-0.43 |
| High | $-0.81 | $-0.15 |
| Analysts (Rev / EPS) | 4 / 2 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $77M | $95M | $112M | $117M | $125M | $130M | $132M |
| Low | $69M | $86M | $93M | $97M | $103M | $107M | $109M |
| High | $82M | $112M | $140M | $146M | $155M | $161M | $164M |
| EBITDA Avg | $12M | $21M | $29M | $43M | $50M | $52M | $55M |
| Low | $6M | $11M | $20M | $38M | $46M | $49M | $52M |
| High | $17M | $34M | $35M | $47M | $52M | $54M | $57M |
| EBIT Avg | $-43M | $-34M | $-28M | $-15M | $-10M | $-10M | $-9M |
| Low | $-48M | $-44M | $-37M | $-20M | $-14M | $-13M | $-12M |
| High | $-38M | $-22M | $-21M | $-11M | $-8M | $-7M | $-7M |
| Net Income Avg | $-44M | $-35M | $-29M | $-16M | $-11M | $-10M | $-9M |
| Low | $-49M | $-45M | $-38M | $-21M | $-15M | $-14M | $-12M |
| High | $-39M | $-23M | $-22M | $-12M | $-9M | $-8M | $-7M |
| EPS Avg | $-0.16 | $-0.13 | $-0.11 | $-0.06 | $-0.04 | $-0.04 | $-0.04 |
| Low | $-0.18 | $-0.17 | $-0.14 | $-0.08 | $-0.05 | $-0.05 | $-0.05 |
| High | $-0.15 | $-0.08 | $-0.08 | $-0.05 | $-0.03 | $-0.03 | $-0.03 |
| Analysts (Rev / EPS) | 5 / 2 | 5 / 2 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 3 / 1 |